| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP Finance &Communications
1 company
Clements Ian is a Chief Financial Officer at MIRM. Recent filings cover 6 purchases and 1 sale. Those positions are worth an estimated $3.0M at current prices.
Our model assigns Clements Ian a middling insider score of 63/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +26.1%.
Clements Ian's largest disclosed position is in MIRM as Chief Financial Officer, worth about $3.0M. Net of sales, the recent Form 4 record there shows accumulation of 6,346 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2021 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 1,450 | $14.14 | $20,505.00 | +4.2% | +74.6% | +48.2% | |
| Oct 1, 2021 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 1,574 | $19.26 | $30,308.94 | -8.6% | -18.8% | +8.6% | |
| Dec 23, 2020 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 2,470 | $18.61 | $45,974.70 | +21.2% | - | - | |
| Sep 6, 2019 | MIRM Mirum Pharmaceuticals, Inc. | SVP Finance &Communications | Buy | 4,000 | $11.51 | $46,039.20 | +222.1% | - | - |